Heading To A Device AdComm? US FDA Details Key Deadlines In Final Guidance
Executive Summary
The newly finalized guidance document discusses how manufacturers should prepare for a panel meeting and the finer points on how the meetings are conducted. It also incorporates some updates from the 21st Century Cures Act.